07:00 , Sep 10, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology Lissencephaly Calpain; lissencephaly-1 (PAFAH1B1; LIS1; LIS2) In vitro and mouse studies suggest that inhibiting calpain could help treat lissencephaly, a disease caused by a...